摘要
The tumor stroma of pancreatic ductal adenocarcinoma (PDAC) is characterized by an abundant and heterogeneous population of cancer-associated fibroblasts (CAFs), which are critically involved in chemoresistance. However, the underlying mechanism of CAFs in chemoresistance is unclear. Here, we show that CAF(R), a CAF subset derived from platinum-resistant PDAC patients, assumes an iCAF phenotype and produces more IL8 than CAF(S) isolated from platinum-sensitive PDAC patients. CAF(R)-derived IL8 promotes oxaliplatin chemoresistance in PDAC. Based on long noncoding RNA (lncRNA) profiling in tumor cells incubated with CAF-CM, we found that UPK1A-AS1, whose expression is directly induced by IL8/NF-kappa B signaling, functions as a chemoresistance-promoting lncRNA and is critical for active IL8-induced oxaliplatin resistance. Impressively, blocking the activation of UPK1A-AS1 expression increases the oxaliplatin sensitivity of tumor cells in vivo. Mechanistically, UPK1A-AS1 strengthens the interaction between Ku70 and Ku80 to facilitate nonhomologous end joining (NHEJ), thereby enhancing DNA double-strand break (DSB) repair. Clinically, UPK1A-AS1 expression is positively correlated with IL8 expression, a poor chemotherapeutic response and a shorter progression-free survival (PFS) time in advanced PDAC patients. Collectively, our study reveals a lncRNA-mediated mechanism of CAF-derived paracrine IL8-dependent oxaliplatin resistance and highlights UPK1A-AS1 as a potential therapeutic target.
学科与关键词
- Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancerZheng, Shangyou; Tian, Qing; Yuan, Yuan; Sun, Shuxin; Li, Tingting; Xia, Renpeng; He, Rihua; Luo, Yuming; Lin, Qing; Fu, Zhiqiang; Zhou, Yu*; Chen, Rufu*; Hu, Chonghui*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42(1): 324.
- circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axisHu, Chonghui; Xia, Renpeng; Zhang, Xiang; Li, Tingting; Ye, Yuancheng; Li, Guolin; He, Rihua; Li, Zhihua; Lin, Qing*; Zheng, Shangyou*; Chen, Rufu*Molecular Cancer, 2022, 21(1): 24.被引 57
- HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1Xia, Renpeng; Hu, Chonghui; Ye, Yuancheng; Zhang, Xiang; Li, Tingting; He, Rihua; Zheng, Shangyou; Wen, Xiaofeng*; Chen, Rufu*International Journal of Oncology, 2023, 62(4): 45.被引 2
